1. Home
  2. IBP vs DNTH Comparison

IBP vs DNTH Comparison

Compare IBP & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Installed Building Products Inc.

IBP

Installed Building Products Inc.

HOLD

Current Price

$240.97

Market Cap

6.3B

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$115.96

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBP
DNTH
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.5B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
IBP
DNTH
Price
$240.97
$115.96
Analyst Decision
Hold
Strong Buy
Analyst Count
8
13
Target Price
$266.14
$121.00
AVG Volume (30 Days)
353.1K
751.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.18%
N/A
EPS Growth
6.70
N/A
EPS
3.71
N/A
Revenue
$2,970,800,000.00
$2,036,000.00
Revenue This Year
$1.96
N/A
Revenue Next Year
$4.32
$29.48
P/E Ratio
$64.75
N/A
Revenue Growth
1.00
N/A
52 Week Low
$193.11
$20.71
52 Week High
$349.00
$116.47

Technical Indicators

Market Signals
Indicator
IBP
DNTH
Relative Strength Index (RSI) 55.18 61.15
Support Level $232.57 $79.27
Resistance Level $253.51 N/A
Average True Range (ATR) 11.26 5.91
MACD 0.84 -0.05
Stochastic Oscillator 61.43 93.10

Price Performance

Historical Comparison
IBP
DNTH

About IBP Installed Building Products Inc.

Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: